Idera Unveils TLR Antagonist Data In Preclinical Model Of Atherosclerosis
The presentation entitled ‘A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis’ was made by Idera scientists at the American
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.